Literature DB >> 11041852

Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.

K A Lehmann1, B L Bass.   

Abstract

Adenosine deaminases that act on RNA (ADARs) deaminate adenosines to produce inosines within RNAs that are largely double-stranded (ds). Like most dsRNA binding proteins, the enzymes will bind to any dsRNA without apparent sequence specificity. However, once bound, ADARs deaminate certain adenosines more efficiently than others. Most of what is known about the intrinsic deamination specificity of ADARs derives from analyses of Xenopus ADAR1. In addition to ADAR1, mammalian cells have a second ADAR, named ADAR2; the deamination specificity of this enzyme has not been rigorously studied. Here we directly compare the specificity of human ADAR1 and ADAR2. We find that, like ADAR1, ADAR2 has a 5' neighbor preference (A approximately U > C = G), but, unlike ADAR1, also has a 3' neighbor preference (U = G > C = A). Simultaneous analysis of both neighbor preferences reveals that ADAR2 prefers certain trinucleotide sequences (UAU, AAG, UAG, AAU). In addition to characterizing ADAR2 preferences, we analyzed the fraction of adenosines deaminated in a given RNA at complete reaction, or the enzyme's selectivity. We find that ADAR1 and ADAR2 deaminate a given RNA with the same selectivity, and this appears to be dictated by features of the RNA substrate. Finally, we observed that Xenopus and human ADAR1 deaminate the same adenosines on all RNAs tested, emphasizing the similarity of ADAR1 in these two species. Our data add substantially to the understanding of ADAR2 specificity, and aid in efforts to predict which ADAR deaminates a given editing site adenosine in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11041852     DOI: 10.1021/bi001383g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  149 in total

1.  Specific cleavage of hyper-edited dsRNAs.

Authors:  A D Scadden; C W Smith
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

Review 2.  RNA editing by adenosine deaminases that act on RNA.

Authors:  Brenda L Bass
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

3.  Nucleocytoplasmic distribution of human RNA-editing enzyme ADAR1 is modulated by double-stranded RNA-binding domains, a leucine-rich export signal, and a putative dimerization domain.

Authors:  Alexander Strehblow; Martina Hallegger; Michael F Jantsch
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

4.  Widespread RNA editing of embedded alu elements in the human transcriptome.

Authors:  Dennis D Y Kim; Thomas T Y Kim; Thomas Walsh; Yoshifumi Kobayashi; Tara C Matise; Steven Buyske; Abram Gabriel
Journal:  Genome Res       Date:  2004-09       Impact factor: 9.043

5.  A survey of RNA editing in human brain.

Authors:  Matthew Blow; P Andrew Futreal; Richard Wooster; Michael R Stratton
Journal:  Genome Res       Date:  2004-11-15       Impact factor: 9.043

6.  Accurate identification of A-to-I RNA editing in human by transcriptome sequencing.

Authors:  Jae Hoon Bahn; Jae-Hyung Lee; Gang Li; Christopher Greer; Guangdun Peng; Xinshu Xiao
Journal:  Genome Res       Date:  2011-09-29       Impact factor: 9.043

Review 7.  Substitutional A-to-I RNA editing.

Authors:  Bjorn-Erik Wulff; Kazuko Nishikura
Journal:  Wiley Interdiscip Rev RNA       Date:  2010 Jul-Aug       Impact factor: 9.957

Review 8.  Adenosine deaminases acting on RNA, RNA editing, and interferon action.

Authors:  Cyril X George; Zhenji Gan; Yong Liu; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2010-12-23       Impact factor: 2.607

9.  Large-scale detection and analysis of adenosine-to-inosine RNA editing during development in Plutella xylostella.

Authors:  Tao He; Wenjie Lei; Chang Ge; Peng Du; Li Wang; Fei Li
Journal:  Mol Genet Genomics       Date:  2014-12-10       Impact factor: 3.291

10.  Effects of conserved RNA secondary structures on hepatitis delta virus genotype I RNA editing, replication, and virus production.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.